# Non-interventional Pre-screening Protocol Aims to Evaluate Participants for Potential Trial Eligibility in Future Clinical Trials/Studies Focusing on Metabolic and Psychiatric Health.

> **NCT07106879** · — · RECRUITING · sponsor: **Clindove Research LLC** · enrollment: 7000 (estimated)

## Conditions studied

- Cardiovascular Diseases
- Metabolic Syndrome
- Obesity
- Prediabetes
- Mental Health Disorders
- Endocrine Dysfunction
- Type 2 Diabetes Mellitus (T2DM)
- Chronic Kidney Disease (CKD)

## Interventions

- **OTHER:** Blood Work

## Key facts

- **NCT ID:** NCT07106879
- **Lead sponsor:** Clindove Research LLC
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2025-07-30
- **Primary completion:** 2030-07-01
- **Final completion:** 2030-12-01
- **Target enrollment:** 7000 (ESTIMATED)
- **Last updated:** 2025-08-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07106879

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07106879, "Non-interventional Pre-screening Protocol Aims to Evaluate Participants for Potential Trial Eligibility in Future Clinical Trials/Studies Focusing on Metabolic and Psychiatric Health.". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT07106879. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*